Taken from ASBMB’s monthly research newsletter: The Monthly Digest (Feb. 2022, Issue 2).
Written by Samme Xie
Molnupiravir: The first oral drug approved to use against COVID-19
Pathways for Undergraduate Researchers at Emory
Emory's chapter of the American Society for Biochemistry and Molecular Biology (ASBMB)'s research-focused website.